HCA
ONC icon

Harbour Capital Advisors’s BeOne Medicines Ltd ONC Stock Holding History

Harbour Capital Advisors’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,545
Closed -$462K – 300
2023
Q4 		$462K Sell
2,545
-190
-7% -$34.4K 0.13% 166
2023
Q3 		$492K Sell
2,735
-175
-6% -$34.6K 0.15% 145
2023
Q2 		$526K Buy
2,910
+35
+1% +$8.06K 0.16% 131
2023
Q1 		$620K Hold
2,875
– – 0.19% 125
2022
Q4 		$652K Sell
2,875
-20
-0.7% -$3.67K 0.22% 102
2022
Q3 		$379K Buy
+2,895
New +$497K 0.13% 149

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Harbour Capital Advisors's ONC Position: Q1 2024 in Review

Harbour Capital Advisors sold out of BeOne Medicines Ltd (ONC) in Q1 2024, closing a stake of 2,545 shares — an estimated $462K sold.

Harbour Capital Advisors first reported a position in ONC in Q3 2022 and held it in 6 quarters. The position peaked at $652K in Q4 2022. 205 funds tracked by Wall St. Rank hold ONC as of Q1 2024.

  • Harbour Capital Advisors reported no remaining BeOne Medicines Ltd position as of Q1 2024 after selling out during the quarter.
  • Harbour Capital Advisors sold 2,545 BeOne Medicines Ltd shares in Q1 2024, an estimated $462K.
  • Harbour Capital Advisors first reported a position in BeOne Medicines Ltd in Q3 2022 and held it in 6 quarters.
  • Harbour Capital Advisors's BeOne Medicines Ltd position peaked at $652K in Q4 2022.
  • 205 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q1 2024.

Based on Harbour Capital Advisors's 13F filing for Q1 2024, filed 16 Apr 2024.